Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Allarity Therapeutics, Inc. - Common stock
(NQ:
ALLR
)
1.770
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Allarity Therapeutics, Inc. - Common stock
< Previous
1
2
3
Next >
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Allarity, Metagenomi, and New Fortress and Encourages Investors to Contact the Firm
October 01, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALLR
September 30, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
ALLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Allarity Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
September 29, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Shareholder Rights Law Firm Robbins LLP Encourages Allarity Therapeutics, Inc. Stockholders with Large Losses to Contact the Firm for Information About the ALLR Securities Class Action
September 27, 2024
From
Robbins LLP
Via
Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Allarity, Agenus, and New Fortress and Encourages Investors to Contact the Firm
September 26, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ALLR CLASS ACTION REMINDER - Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Allarity Therapeutics, Inc. Securities Class Action
September 24, 2024
From
Robbins LLP
Via
GlobeNewswire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Allarity Therapeutics, Inc. (ALLR)
September 23, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sage, Outset Medical, Allarity, and Super Micro and Encourages Investors to Contact the Firm
September 22, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
ALLR Lawsuit Reminder - Robbins LLP Reminds Stockholders of the Allarity Therapeutics, Inc. Class Action Lawsuit
September 20, 2024
From
Robbins LLP
Via
Business Wire
ALLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Allarity Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
September 20, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
ROSEN, A LEADING LAW FIRM, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALLR
September 20, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Allarity Therapeutics, Inc. (ALLR)
September 20, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Allarity Therapeutics, Inc. (ALLR) Investors
September 19, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
ALLARITY ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Allarity Therapeutics, Inc. and Encourages Investors to Contact the Firm
September 17, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Rosen Law Firm Urges Allarity Therapeutics, Inc. (NASDAQ: ALLR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
September 17, 2024
From
Rosen Law Firm
Via
Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Allarity Therapeutics, Inc. (ALLR) Investors
September 17, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Allarity Therapeutics, Inc.
September 16, 2024
From
Robbins LLP
Via
GlobeNewswire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Allarity Therapeutics, Inc. (ALLR) Investors
September 16, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
ALLR Investors Have Opportunity to Lead Allarity Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
September 16, 2024
From
The Schall Law Firm
Via
Business Wire
Allarity Therapeutics Announces Two Patients Now Exceeding One Year of Treatment with Stenoparib in Advanced Ovarian Cancer Trial
September 16, 2024
From
Allarity Therapeutics, Inc.
Via
GlobeNewswire
Allarity Therapeutics Announces New CFO and Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 13, 2024
From
Allarity Therapeutics, Inc.
Via
GlobeNewswire
Allarity Therapeutics Takes Decisive Step Toward Regaining Nasdaq Compliance with Nasdaq Listing Rule 5550(a)(2)
September 11, 2024
From
Allarity Therapeutics, Inc.
Via
GlobeNewswire
ALLARITY THERAPEUTICS, INC. ANNOUNCEMENT: If You Have Suffered Losses in Allarity Therapeutics, Inc. (NASDAQ: ALLR), You Are to Contact The Rosen Law Firm About Your Rights
August 20, 2024
From
The Rosen Law Firm PA
Via
GlobeNewswire
Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
August 05, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Allarity Therapeutics, Inc. (ALLR) on Behalf of Investors
July 30, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Allarity Therapeutics, Inc. (ALLR) on Behalf of Investors
July 30, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Continues Investigation of Allarity Therapeutics, Inc. (ALLR) on Behalf of Investors
July 29, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
July 28, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Allarity Therapeutics Announces Postponement of Annual Stockholders Meeting
July 26, 2024
From
Allarity Therapeutics, Inc.
Via
GlobeNewswire
ALLR Investors Have Opportunity to Join Allarity Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm
July 24, 2024
From
The Schall Law Firm
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.